Try our Advanced Search for more refined results
Health
Health Law360 provides breaking legal news and analysis on the health care industry. Coverage includes litigation, policy developments, and corporate deals involving health care services companies such as hospitals, health insurers, physicians groups, and medical suppliers.
Sign up for a 7-day FREE trial today!
Latest News in Health
-
February 10, 2026
Fresenius Can't Knock Out 401(k) Forfeiture Suit
A Massachusetts federal judge narrowed but declined to dismiss a suit claiming dialysis company Fresenius violated federal benefits law by using forfeited 401(k) funds to pay for match contributions instead of plan fees, ruling the workers behind the suit adequately explained that the move may have flouted their interests.
-
February 10, 2026
Whooping Cough-Focused Biotech Wraps $115M Fundraise
Florida-based biotechnology company ILiAD Biotechnologies Inc. on Tuesday revealed that it wrapped its latest financing round after securing $115 million from investors, which will be used to advance development on a potential whooping cough vaccine.
-
February 09, 2026
9th Circ. Judge Casts Doubt On Feds' Grant Condition Stance
A Ninth Circuit judge expressed skepticism Monday as the Trump administration argued it could legally impose new rules barring federal grant recipients from using the money for diversity programming, suggesting that the government had misread Title VI of the Civil Rights Act of 1964.
-
February 09, 2026
Kurin Fights $1.6M IP Verdict As Rival Seeks More Damages
Kurin has urged a Delaware federal judge to overturn Magnolia Medical's $1.6 million patent verdict or order a new trial, while Magnolia Medical has asked the court to bar Kurin from selling allegedly infringing "Jet" blood-culture collection products and award it supplemental damages on Kurin's sales, plus ongoing royalties and interest.
-
February 09, 2026
Defendant Mix-Up Ends Biotech FCA Suit, For Now
A New York federal court ruled that a relator's False Claims Act suit failed to link claims of improper COVID-19 billing and other alleged schemes to defraud Medicare to the biotech company it named as a defendant, dismissing the complaint with leave to amend.
Areas of Coverage
- AGENCIES
- U.S. Department of Health and Human Services
- Centers for Medicare and Medicaid Services
- State and international health care regulators
- POLICY & REGULATION
- Affordable Care Act
- Health Insurance Portability and Accountability Act
- Patient’s Bill of Rights
- Stark Law
- Consumer protection controls
- Tax-related issues
- Health care lobbying
- State and international health care legislation and regulation
- ENFORCEMENT
- Health care fraud investigations
- Merger reviews
- LITIGATION
- Medical malpractice and liability suits
- Mass torts
- Health care fraud disputes
- Insurance coverage suits
- Reimbursement disputes
- Whistleblower and anti-corruption compliance suits
- Antitrust suits
- Breach of contract suits
- Labor and employment issues
- Shareholder disputes
- Bankruptcy proceedings
- TRANSACTIONS
- Mergers, acquisitions, and joint ventures
- Health care project finance and real estate deals
- PROFILES
- Personnel moves
- Profiles of health attorneys
Readership
- Health care lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the health care services industry
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals